Purchase Order 75N93020P01171
- Not listed
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The $16,199.95 contract is for the delivery of BIOLEGEND antibodies to support NIAID's research initiatives, which may include studies related to COVID-19, immunology, and other disease areas. The contract does not...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical research products. The contract, valued at $7,190.00, is for the delivery of antibodies. There is no set-aside designation for this contract. Biolegend, Inc. is the prime contractor and has not...
- This is a $98,517.25 firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other products supporting life science research and drug discovery. The contract, awarded on January 28, 2021, is for the procurement of COVID-19 research antibodies, with a period of performance through January 26, 2022....
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Biolegend, Inc. for the supply of various biomedical research reagents and antibodies. The $3,088.75 contract supports research efforts across multiple federal agencies, particularly within the NIAID. Biolegend, a for-profit manufacturer of life science research products, has a history of providing specialized...
- This federal contract award to Biolegend, Inc. is for the provision of multiple antibodies to support flow cytometry research. The $38,072.50 firm-fixed-price purchase order was awarded on January 12, 2016 by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services. The contract does not have a set-aside designation. Biolegend is a for-profit manufacturer and supplier of biomedical reagents, antibodies, proteins, and other...
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, awarded a $56,762.00 firm-fixed-price purchase order to Biolegend, Inc. for the supply of various biological research products, including Alexa Fluor 700 anti-human IFN-γ and several Brilliant Violet-labeled antibodies for human cellular markers. This acquisition was processed under Simplified Acquisition Procedures without a small business set-aside. Biolegend, a...
- This is a firm-fixed-price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Biolegend, Inc. The contract is for the delivery of various antibodies and related biomedical reagents to support research efforts. The contract has a ceiling value of $4,286.20 and an ultimate completion date of July 1, 2016. Biolegend, Inc. is a for-profit manufacturer and supplier of biomedical products, with...
- This $5,373.75 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Biolegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, and other life science research products. The contract is for the delivery of anti-mouse IgM reagents to support NIAID's research initiatives, which may include areas such as COVID-19, multiple sclerosis, and other...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $22,041.90 purchase order to Biolegend, Inc., a medical division of Revvity Inc., for BIOLEGEND ANTIBODIES. The firm fixed price order runs from September 1, 2023 through October 31, 2023 for place of performance in San Diego, California. No major subcontractors or set aside designations were indicated. This small purchase supports the NIH/NIAID's research...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order contract worth $8,377.50 to Biolegend, Inc., a for-profit manufacturer of biomedical reagents and antibodies. The contract is for the delivery of "Brilliant Violet Anti-Human Antibodies" to support the agency's research efforts. Biolegend, Inc. is a subsidiary of the parent company Revvity Inc. This contract award does not have a set-aside designation. The contract has an ultimate completion date of November 29, 2022. As a specialized supplier of reagents and antibodies for life science research, Biolegend has received numerous contract awards from NIAID and other NIH components to support initiatives in areas such as COVID-19, multiple sclerosis, infectious diseases, and immunology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($3k) | 3/28/25 | |
| P00001 | Other Administrative Action | $0 | 11/29/22 | |
| Not listed | Not listed | $11.3k | 8/22/20 |